Mgr. Lenka Bešše, Ph.D.
Head of the research group, Lenka Bešše Research Group: Cancer Immunotherapy Research
office: bldg. A19/219
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 5363 |
---|---|
e‑mail: |
Total number of publications: 70
2024
-
A replicating LCMV-based vaccine for the treatment of solid tumors
Molecular Therapy, year: 2024, volume: 32, edition: 2, DOI
-
HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer
British journal of cancer, year: 2024, DOI
2023
-
Lékařská biologie I. Buněčná a molekulární biologie
Year: 2023, type:
-
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, year: 2023, volume: 12, edition: 1, DOI
2022
-
Medical biology I. Cell and Molecular Biology
Year: 2022, type:
2017
-
Cell-free DNA — Minimally invasive marker of hematological malignancies
European Journal of Haematology, year: 2017, volume: 99, edition: 4, DOI
2016
-
Cytogenetics in multiple myeloma patients progressing into extramedullary disease
European Journal of Haematology, year: 2016, volume: 97, edition: 1, DOI
-
Detekce minimální reziduální choroby u mnohočetného myelomu pomocí mimobuněčné DNA
Year: 2016, type: Conference abstract
2015
-
Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma
Plos One, year: 2015, volume: 10, edition: 9, DOI
-
Cirkulující mikroRNA v moči jako biomarker mnohočetného myelomu
Year: 2015, type: Conference abstract